凝血酶/抗凝血酶复合体(TAT)重组蛋白
Recombinant Thrombin/Antithrombin Complex (TAT)
- 编号RPA831Hu01
- 物种Homo sapiens (Human，人) 相同的名称，不同的物种。
- 来源原核表达
- 宿主E.coli
- 内毒素水平<1.0EU/µg(LAL法测定)
- 亚细胞定位分泌
- 预测分子量83.4kDa
- 实际分子量83kDa(差异分析请参阅说明书)
- 片段与标签Ile364~Glu622+GGGGS*3+His33~Lys464 with N-terminal His Tag
- 缓冲液成份20mM Tris, 150mM NaCl, pH8.0, containing 0.01% SKL, 5% Trehalose.
- 性状冻干粉
- 纯度> 80%
- 等电点7.8
-
应用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，请参见活性蛋白。 - 下载 英文说明书 中文说明书
- 规格 10µg50µg 200µg 1mg 5mg
- 价格 ¥ 840 ¥ 2100 ¥ 4200 ¥ 12600 ¥ 31500
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
-
产品包装(模拟)
-
产品包装(模拟)
-
Figure. SDS-PAGE
-
通过ISO 9001、ISO 13485质量体系认证
序列
用法
Reconstitute in ddH2O to a concentration of 0.1-0.4 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月，-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
增值服务
相关产品
| 编号 | 适用物种：Homo sapiens (Human，人) | 应用(仅供研究使用，不用于临床诊断！) |
| EPA831Hu61 | 凝血酶/抗凝血酶复合体(TAT)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA831Hu01 | 凝血酶/抗凝血酶复合体(TAT)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| MAA831Hu21 | 凝血酶/抗凝血酶复合体(TAT)单克隆抗体 | WB |
| MAA831Hu24 | 凝血酶/抗凝血酶复合体(TAT)单克隆抗体 | WB; IHC; ICC; IP. |
| MAA831Hu25 | 凝血酶/抗凝血酶复合体(TAT)单克隆抗体 | WB; IHC; ICC; IP. |
| MAA831Hu22 | 凝血酶/抗凝血酶复合体(TAT)单克隆抗体 | WB; IHC; ICC; IP. |
| MAA831Hu23 | 凝血酶/抗凝血酶复合体(TAT)单克隆抗体 | WB; IHC; ICC; IP. |
| MAA831Hu27 | 凝血酶/抗凝血酶复合体(TAT)单克隆抗体 | WB; IHC; ICC; IP. |
| SEA831Hu | 凝血酶/抗凝血酶复合体(TAT)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA831Hu | 凝血酶/抗凝血酶复合体(TAT)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
| 杂志 | 参考文献 |
| IUBMB LIFE | Genetic repression of mouse VEGF expression regulates coagulation cascade. [PubMed: 21086498] |
| Thrombosis Research | Treatment with unfractionated heparin attenuates coagulation and inflammation in endotoxemic mice [ScienceDirect: S0049384811004166] |
| Journal of Thrombosis and Haemostasis | High sCD40L levels early after trauma are associated with enhanced shock, sympathoadrenal activation, tissue and endothelial damage, coagulopathy and mortality [Wiley: source] |
| 3 | Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling [Nature: 20120329] |
| Am J Respir Cell Mol Bio | Prolonged Exposure to Sphingosine 1–Phosphate Receptor-1 Agonists Exacerbates Vascular Leak, Fibrosis, and Mortality after Lung Injury [PubMed: PMC2993087] |
| PLoS One | Host Defense Peptides of Thrombin Modulate Inflammation and Coagulation in Endotoxin-Mediated Shock and Pseudomonas aeruginosa Sepsis [PubMed: PMC3521733] |
| Haemetology | Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India [Pubmed: 23992124] |
| Am J Transl Res. | Selected hemostatic parameters in patients with pancreatic tumors. [Pubmed:Pmc4297344] |
| PLOS ONE | TFPI1 Mediates Resistance to Doxorubicin in Breast Cancer Cells by Inducing a Hypoxic-Like Response [Pubmed:24489651] |
| Leukemia | Novel evidence that crosstalk between the complement, coagulation and fibrinolysis proteolytic cascades is involved in mobilization of hematopoietic stem/progenitor cells (HSPCs) [Pubmed:24667943] |
| Anesthesia & Analgesia | Thrombomodulin Improved Liver Injury, Coagulopathy, and Mortality in an Experimental Heatstroke Model in Mice [Pubmed:24781566] |
| Cell Transplantation | Evidence of a Pivotal Role for the Distal Part of the Complement Cascade in the Diurnal Release of Hematopoietic Stem Cells Into Peripheral Blood [Pubmed:26087465] |
| European Journal of Pharmacology | (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coaCavia (Guinea pig )lation [Pubmed:27343380] |
| J Thromb Haemost. | Coagulation factor XI vaccination: an alternative strategy to prevent thrombosis. [pubmed:27813324] |
| Blood Cells, Inflammation and Infection | Nebulized Heparin Attenuates Pulmonary Coagulopathy and Inflammation through Alveolar Macrophages in a Rat Model of Acute Lung Injury [pubmed:29202212] |
| SCIENCE TRANSLATIONAL MEDICINE | Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertension [pubmed:28148841] |
| 32 | Activated TAFI Promotes the Development of Chronic Thromboembolic Pulmonary Hypertension: A Possible Novel Therapeutic Target [pubmed:28289017] |
| Thrombosis andHaemostasis | Nebulized anti-coagulants as a therapy for acute lung injury and acute respiratory distress syndrome [Pubmed: 29202212] |
| Thrombosis Research | The circadian rhythm of selected parameters of the hemostasis system in healthy people [] |
| Experimental Neurobiology | Transduced Tat-aldose Reductase Protects Hippocampal Neuronal Cells against Oxidative Stress-induced Damage [Pubmed: 31698553] |
| LIVER TRANSPLANTATION | The impact of dabigatran treatment on sinusoidal protection against hepatic ischemia‐reperfusion injury in mice [Pubmed: 33108682] |
| Am J Physiol Heart Circ Physiol | Doxorubicin contributes to thrombus formation and vascular injury via enhancing platelet functions in vivo [Pubmed: 32469636] |
| Intensive Care Medicine Experimental | Preservation of renal endothelial integrity and reduction of renal edema by aprotinin does not preserve renal perfusion and function following experimental … [34169407] |
| Intensive Care Med Exp | Complement factor D is linked to platelet activation in human and rodent sepsis [34396466] |
留言咨询